We are analyzing https://link.springer.com/article/10.1007/s10585-014-9637-6.

Title:
Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells | Clinical & Experimental Metastasis
Description:
Tumor cell plasticity largely depends on epithelial-to-mesenchymal transition (EMT) and its reversion. It was ascertained that EMT characterizes disease progression, including melanoma malignancy. As most solid tumors, melanoma shows extracellular acidosis, we analyse the impact of acidic environment on the EMT development in human melanoma cells. Melanoma cells were exposed to an acidic extracellular environment (pH 6.7) and tested for EMT markers. We found that acidic cells express a significant up-regulation of mesenchymal markers (N-cadherin, Vimentin), transcription factors (Twist, NF-κB) and a significant, although modest, reduction of E-cadherin expression. Acidic cell also express an increased invasiveness through Matrigel associated with an up-regulation of MMP-9 activity. When we injected acidic cells intravenously into immunodeficient animals, we found a number of lung micrometastases not different from non-acidic cells. Indeed, they show a partial G1 cell cycle arrest, which might interfere with the growth of lung colonies. When we investigated the in vitro invasiveness and lung colonization of a mixed population of acidic and non acidic melanoma cells, we found that acidic cells promote in vitro invasiveness of non-acidic cells and this cooperation leads to an higher migration rate than acidic cells. Moreover, acidic cells cooperate for a better lung colonization of non-acidic cells, that represent the greater part of cells participating to lung micrometastases. We found evidence that acidity triggers in melanoma cells an EMT program, which although “incomplete”, potentiates migration rate and development of lung colonies into immunodeficient host of cells grown in standard pH.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

pubmed, article, google, scholar, cas, cells, cell, cancer, melanoma, acidic, metastasis, transition, epithelialmesenchymal, central, tumor, human, res, biol, bianchini, calorini, extracellular, lung, clin, nat, rev, peppicelli, emt, expression, migration, weinberg, exp, privacy, cookies, content, nonacidic, torre, development, access, transitions, publish, research, search, epithelialtomesenchymal, lido, progression, found, invasiveness, acidity, invasion, yang,

Topics {✒️}

twist1-induced epithelial–mesenchymal transition month download article/chapter nf-κb favours vegf eugenio torre & lido calorini istituto toscano tumori epithelial–mesenchymal transition full article pdf higher migration rate potentiates migration rate epithelial–mesenchymal transitions università di firenze tumor cell progression tumour-cell invasion human melanoma cells changing cell state acidic melanoma cells acidic melanoma cells murine tumor cells nf-κb privacy choices/manage cookies including melanoma malignancy melanoma cells selects related subjects rodríguez-peralto jl rofstad ek cancer invasion front tgf-beta signaling human glial cells acidic extracellular environment acidic cells promote acidic cells cooperate article peppicelli mesenchymal transition human normal melanocytes high aerobic glycolysis stem cell traits metastatic dissemination cultured mammalian cells de herreros ag tumor metastasis prostate cancer cells acidic cells express european economic area van der wall van diest pj restricted patient survival radioresistance secon-dary athymic nude mice lido calorini article log

Questions {❓}

Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells
         description:Tumor cell plasticity largely depends on epithelial-to-mesenchymal transition (EMT) and its reversion. It was ascertained that EMT characterizes disease progression, including melanoma malignancy. As most solid tumors, melanoma shows extracellular acidosis, we analyse the impact of acidic environment on the EMT development in human melanoma cells. Melanoma cells were exposed to an acidic extracellular environment (pH 6.7) and tested for EMT markers. We found that acidic cells express a significant up-regulation of mesenchymal markers (N-cadherin, Vimentin), transcription factors (Twist, NF-κB) and a significant, although modest, reduction of E-cadherin expression. Acidic cell also express an increased invasiveness through Matrigel associated with an up-regulation of MMP-9 activity. When we injected acidic cells intravenously into immunodeficient animals, we found a number of lung micrometastases not different from non-acidic cells. Indeed, they show a partial G1 cell cycle arrest, which might interfere with the growth of lung colonies. When we investigated the in vitro invasiveness and lung colonization of a mixed population of acidic and non acidic melanoma cells, we found that acidic cells promote in vitro invasiveness of non-acidic cells and this cooperation leads to an higher migration rate than acidic cells. Moreover, acidic cells cooperate for a better lung colonization of non-acidic cells, that represent the greater part of cells participating to lung micrometastases. We found evidence that acidity triggers in melanoma cells an EMT program, which although “incomplete”, potentiates migration rate and development of lung colonies into immunodeficient host of cells grown in standard pH.
         datePublished:2014-01-28T00:00:00Z
         dateModified:2014-01-28T00:00:00Z
         pageStart:423
         pageEnd:433
         sameAs:https://doi.org/10.1007/s10585-014-9637-6
         keywords:
            Extracellular acidity
            Epithelial-to-mesenchymal transition
            NF-κB
            Invasiveness
            Tumor cell dissemination
            Human melanoma
            Cancer Research
            Biomedicine
            general
            Oncology
            Hematology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig5_HTML.gif
         isPartOf:
            name:Clinical & Experimental Metastasis
            issn:
               1573-7276
               0262-0898
            volumeNumber:31
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Silvia Peppicelli
               affiliation:
                     name:Università di Firenze
                     address:
                        name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                        type:PostalAddress
                     type:Organization
                     name:Istituto Toscano Tumori
                     address:
                        name:Istituto Toscano Tumori, Florence, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Francesca Bianchini
               affiliation:
                     name:Università di Firenze
                     address:
                        name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                        type:PostalAddress
                     type:Organization
                     name:Istituto Toscano Tumori
                     address:
                        name:Istituto Toscano Tumori, Florence, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eugenio Torre
               affiliation:
                     name:Università di Firenze
                     address:
                        name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                        type:PostalAddress
                     type:Organization
                     name:Istituto Toscano Tumori
                     address:
                        name:Istituto Toscano Tumori, Florence, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lido Calorini
               affiliation:
                     name:Università di Firenze
                     address:
                        name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                        type:PostalAddress
                     type:Organization
                     name:Istituto Toscano Tumori
                     address:
                        name:Istituto Toscano Tumori, Florence, Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells
      description:Tumor cell plasticity largely depends on epithelial-to-mesenchymal transition (EMT) and its reversion. It was ascertained that EMT characterizes disease progression, including melanoma malignancy. As most solid tumors, melanoma shows extracellular acidosis, we analyse the impact of acidic environment on the EMT development in human melanoma cells. Melanoma cells were exposed to an acidic extracellular environment (pH 6.7) and tested for EMT markers. We found that acidic cells express a significant up-regulation of mesenchymal markers (N-cadherin, Vimentin), transcription factors (Twist, NF-κB) and a significant, although modest, reduction of E-cadherin expression. Acidic cell also express an increased invasiveness through Matrigel associated with an up-regulation of MMP-9 activity. When we injected acidic cells intravenously into immunodeficient animals, we found a number of lung micrometastases not different from non-acidic cells. Indeed, they show a partial G1 cell cycle arrest, which might interfere with the growth of lung colonies. When we investigated the in vitro invasiveness and lung colonization of a mixed population of acidic and non acidic melanoma cells, we found that acidic cells promote in vitro invasiveness of non-acidic cells and this cooperation leads to an higher migration rate than acidic cells. Moreover, acidic cells cooperate for a better lung colonization of non-acidic cells, that represent the greater part of cells participating to lung micrometastases. We found evidence that acidity triggers in melanoma cells an EMT program, which although “incomplete”, potentiates migration rate and development of lung colonies into immunodeficient host of cells grown in standard pH.
      datePublished:2014-01-28T00:00:00Z
      dateModified:2014-01-28T00:00:00Z
      pageStart:423
      pageEnd:433
      sameAs:https://doi.org/10.1007/s10585-014-9637-6
      keywords:
         Extracellular acidity
         Epithelial-to-mesenchymal transition
         NF-κB
         Invasiveness
         Tumor cell dissemination
         Human melanoma
         Cancer Research
         Biomedicine
         general
         Oncology
         Hematology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-014-9637-6/MediaObjects/10585_2014_9637_Fig5_HTML.gif
      isPartOf:
         name:Clinical & Experimental Metastasis
         issn:
            1573-7276
            0262-0898
         volumeNumber:31
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Silvia Peppicelli
            affiliation:
                  name:Università di Firenze
                  address:
                     name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                     type:PostalAddress
                  type:Organization
                  name:Istituto Toscano Tumori
                  address:
                     name:Istituto Toscano Tumori, Florence, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Francesca Bianchini
            affiliation:
                  name:Università di Firenze
                  address:
                     name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                     type:PostalAddress
                  type:Organization
                  name:Istituto Toscano Tumori
                  address:
                     name:Istituto Toscano Tumori, Florence, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eugenio Torre
            affiliation:
                  name:Università di Firenze
                  address:
                     name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                     type:PostalAddress
                  type:Organization
                  name:Istituto Toscano Tumori
                  address:
                     name:Istituto Toscano Tumori, Florence, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lido Calorini
            affiliation:
                  name:Università di Firenze
                  address:
                     name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
                     type:PostalAddress
                  type:Organization
                  name:Istituto Toscano Tumori
                  address:
                     name:Istituto Toscano Tumori, Florence, Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical & Experimental Metastasis
      issn:
         1573-7276
         0262-0898
      volumeNumber:31
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Università di Firenze
      address:
         name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
         type:PostalAddress
      name:Istituto Toscano Tumori
      address:
         name:Istituto Toscano Tumori, Florence, Italy
         type:PostalAddress
      name:Università di Firenze
      address:
         name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
         type:PostalAddress
      name:Istituto Toscano Tumori
      address:
         name:Istituto Toscano Tumori, Florence, Italy
         type:PostalAddress
      name:Università di Firenze
      address:
         name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
         type:PostalAddress
      name:Istituto Toscano Tumori
      address:
         name:Istituto Toscano Tumori, Florence, Italy
         type:PostalAddress
      name:Università di Firenze
      address:
         name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
         type:PostalAddress
      name:Istituto Toscano Tumori
      address:
         name:Istituto Toscano Tumori, Florence, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Silvia Peppicelli
      affiliation:
            name:Università di Firenze
            address:
               name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
               type:PostalAddress
            type:Organization
            name:Istituto Toscano Tumori
            address:
               name:Istituto Toscano Tumori, Florence, Italy
               type:PostalAddress
            type:Organization
      name:Francesca Bianchini
      affiliation:
            name:Università di Firenze
            address:
               name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
               type:PostalAddress
            type:Organization
            name:Istituto Toscano Tumori
            address:
               name:Istituto Toscano Tumori, Florence, Italy
               type:PostalAddress
            type:Organization
      name:Eugenio Torre
      affiliation:
            name:Università di Firenze
            address:
               name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
               type:PostalAddress
            type:Organization
            name:Istituto Toscano Tumori
            address:
               name:Istituto Toscano Tumori, Florence, Italy
               type:PostalAddress
            type:Organization
      name:Lido Calorini
      affiliation:
            name:Università di Firenze
            address:
               name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
               type:PostalAddress
            type:Organization
            name:Istituto Toscano Tumori
            address:
               name:Istituto Toscano Tumori, Florence, Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
      name:Istituto Toscano Tumori, Florence, Italy
      name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
      name:Istituto Toscano Tumori, Florence, Italy
      name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
      name:Istituto Toscano Tumori, Florence, Italy
      name:Sezione di Patologia e Oncologia Sperimentali, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Florence, Italy
      name:Istituto Toscano Tumori, Florence, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(166)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.69s.

LINK . SPRINGER . COM {}